Understanding cancer at the chromosome level: 40 Years of progress

European Journal of Cancer

Volumn 40, Issue 13, 2004, Pages 1960-1967

  Debernardi, Silvana ^a   Lillington, Debra ^a   Young, Bryan D ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Cancer genetics; Chromosomes; Cytogenetics; Translocations

Indexed keywords

BCR ABL PROTEIN; MYC PROTEIN; RETINOBLASTOMA PROTEIN; TUMOR MARKER;

BURKITT LYMPHOMA; CANCER GENETICS; CANCER RESEARCH; CHROMOSOME DELETION; CHROMOSOME MARKER; CHROMOSOME TRANSLOCATION; CYTOGENETICS; DISEASE ASSOCIATION; DOUBLE MINUTE CHROMOSOME; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; METAPHASE CHROMOSOME; MOLECULAR GENETICS; MOLECULAR MODEL; NEUROBLASTOMA; ONCOGENE; ONCOGENE C MYC; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW;

EID: 4143131006     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.06.007     Document Type: Article

References (40)

1. Hsu T.C. Mammalian chromosomes in vitro I. The karyotype of man. J. Hered. 43:1952;167-172
2. Tjio J.H., Levan A. The chromosome number of man. Hereditas. 42:1956;1
3. Stewart A., Webb J., Hewitt D. Aetiology of childhood malignancies. Brit. Med. J. 1:1961;452-460
4. Levan A. Relation of chromosome status to the origin and progression of tumours. In: Genetics and cancer. London: Peter Owen Ltd; 1961
5. Hauschka T.S. Chromosome patterns in primary neoplasms. Exp. Cell Res. 9:1963;86-98
6. Makino S., Sasaki M.S., Tonomura A. Cytological studies of tumours. XL. Chromosome studies of52 human tumours. J. Natl. Cancer Inst. 32:1964;741-777
7. Spriggs A.I., Boddington M.M., Clarke C.M. Carcinoma of the cervix uteri. Lancet. 1:1962;1383-1384
8. Nowell P.C., Hungerford D.A. Chromosome studies in human leukemia. II. Chronic granulocytic leukemia. J. Natl. Cancer Inst. 27:1961;1013-1035
9. Rowley J.D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 243(5405):1973;290-293
10. Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R.C., Croce C.M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA. 79(24):1982;7824-7827
11. Emanuel B.S., Balaban G., Boyd J.P., Grossman A., Negishi M., Parmiter A., et al. N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas. Proc. Natl. Acad. Sci. USA. 82(11):1985;3736-3740
12. Lele K.P., Penrose L.S., Stallard H.B. Chromosome deletion in a case of retinoblastoma. Am. J. Hum. Genet. 27:1963;171-173
13. Friend S.H., Bernards R., Rogelj S., Weinberg R.A., Rapaport J.M., Albert D.M., et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323(6089):1986;643-646
14. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The medical research council adult and children's leukaemia working parties. Blood. 92(7):1998;2322-2333
15. Speicher M.R., Gwyn Ballard S., Ward D.C. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat. Genet. 12(4):1996;368-375
16. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., et al. Multicolor spectral karyotyping of human chromosomes. Science. 273(5274):1996;494-497
17. Veldman T., Vignon C., Schrock E., Rowley J.D., Ried T. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat. Genet. 15(4):1997;406-410
18. Alizadeh A.A., Ross D.T., Perou C.M., van de Rijn M. Towards a novel classification of human malignancies based on gene expression patterns. J. Pathol. 195(1):2001;41-52
19. Zou T.T., Selaru F.M., Xu Y., Shustova V., Yin J., Mori Y., et al. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene. 21(31):2002;4855-4862
20. Lin Y.M., Furukawa Y., Tsunoda T., Yue C.T., Yang K.C., Nakamura Y. Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene. 21(26):2002;4120-4128
21. Notterman D.A., Alon U., Sierk A.J., Levine A.J. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 61(7):2001;3124-3130
22. MacDonald T.J., Brown K.M., LaFleur B., Peterson K., Lawlor C., Chen Y., et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat. Genet. 29(2):2001;143-152
23. Pomeroy S.L., Tamayo P., Gaasenbeek M., Sturla L.M., Angelo M., McLaughlin M.E., et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 415(6870):2002;436-442
24. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., et al. Molecular portraits of human breast tumours. Nature. 406(6797):2000;747-752
25. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA. 98(19):2001;10869-10874
26. van 't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415(6871):2002;530-536
27. Hedenfalk I., Duggan D., Chen Y., Radmacher M., Bittner M., Simon R., et al. Gene-expression profiles in hereditary breast cancer. New Engl. J. Med. 344(8):2001;539-548
28. Jazaeri A.A., Yee C.J., Sotiriou C., Brantley K.R., Boyd J., Liu E.T. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J. Natl. Cancer Inst. 94(13):2002;990-1000
29. Welsh J.B., Zarrinkar P.P., Sapinoso L.M., Kern S.G., Behling C.A., Monk B.J., et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. USA. 98(3):2001;1176-1181
30. Wang K., Gan L., Jeffery E., Gayle M., Gown A.M., Skelly M., et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene. 229(1-2):1999;101-108
31. Takahashi M., Rhodes D.R., Furge K.A., Kanayama H., Kagawa S., Haab B.B., et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc. Natl. Acad. Sci. USA. 98(17):2001;9754-9759
32. LaTulippe E., Satagopan J., Smith A., Scher H., Scardino P., Reuter V., et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 62(15):2002;4499-4506
33. Welsh J.B., Sapinoso L.M., Su A.I., Kern S.G., Wang-Rodriguez J., Moskaluk C.A., et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61(16):2001;5974- 5978
34. Dhanasekaran S.M., Barrette T.R., Ghosh D., Shah R., Varambally S., Kurachi K., et al. Delineation of prognostic biomarkers in prostate cancer. Nature. 412(6849):2001;822-826
35. Hippo Y., Taniguchi H., Tsutsumi S., Machida N., Chong J.M., Fukayama M., et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 62(1):2002;233-240
36. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 286(5439):1999;531-537
37. Armstrong S.A., Staunton J.E., Silverman L.B., Pieters R., den Boer M.L., Minden M.D., et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. 30(1):2002;41-47
38. Schoch C., Kohlmann A., Schnittger S., Brors B., Dugas M., Mergenthaler S., et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc. Natl. Acad. Sci. USA. 99(15):2002;10008-10013
39. Debernardi S., Lillington D., Chaplin T., Tomlinson S., Amess J.A., Rohatiner A.Z., et al. Prognostically important chromosomal events in acute myeloid leukaemia can be deduced from gene expression analysis. Genes Chromosomes Cancer. 37(2):2002;149-158
40. Solinas-Toldo S., Lampel S., Stilgenbauer S., Nickolenko J., Benner A., Dohner H., Cremer T., Lichter P. Matrix-based comparitive genomie hybridisation biochips to screen for genomie imbalances. Genes Chromosomes Cancer. 20(4):1997;399-407